It remains an investigational drug currently being evaluated in Phase 3 clinical trials by Eli Lilly for the treatment of: Obesity (without diabetes) Type 2 diabetes Nonalcoholic fatty liver disease (NAFLD/NASH) Projected Approval Timeline Based on Phase 2 success and accelerated trials, Retatrutide could receive FDA approval as early as 2026 Eli Lilly is positioning it to directly compete with Tirzepatide (Mounjaro) and Semaglutide (Wegovy) Expected to be administered as a once-weekly injection Not Available for Research or Off-Label Use Retatrutide is not legally available on the gray market No legitimate research chemical suppliers offer it any listings claiming to sell Retatrutide are likely counterfeit or misbranded Because of its complex multi-receptor structure, DIY compounding is extremely risky and discouraged Athletic Use and WADA Considerations Like other GLP-1 agonists, Retatrutide is not currently banned by WADA However, its performance-enhancing effects (fat loss, appetite suppression, metabolic acceleration) could put it under scrutiny in the future Athletes in tested federations should proceed cautiously once the drug is commercialized Until Retatrutide clears regulatory approval, its use remains confined to clinical trial settings
Known for its dedication to improving patient access to healthcare, More 33009 : 9:00 am 6:00 pm Mon 9:00 am 6:00 pm Tue 9:00 am 6:00 pm Wed 9:00 am 6:00 pm Thu 9:00 am 6:00 pm Fri 9:00 am 5:00 pm Sat Closed Sun Closed Google Rating: 4.7 (163) Clinic Favorite Body Rejuvenation is a leading anti-aging and wellness center based in Miami, renowned for its innovative beauty and wellness treatments
Huge win for patients who may have fears or trouble giving themselves injections This is going to be insane
L.MarkovicJ.DasF.QuevalG.SchnaubeltD.FoyerC
She now continues her personal training sessions online as well as teaches livestream fitness classes exclusively since her move to Costa Rica in 2014
